Ummm. Probably not significant compared to trial results. It is an indicator of quality. And, that can't hurt.
Sort of like being a sub $5 stock i.e. a penny. Being over $5 doesn't really mean the company is better managed or has better prospects. It does allow a wider world of investment from some instys.